Move the program forward. Strengthen the business behind it

I’m Jennifer Lee. I advise biotech and pharma leaders, investors, and companies serving life sciences on development strategy and the operating decisions that affect performance.

That may mean getting a stalled program moving, preparing a company for its next stage, or assessing whether a development plan is realistic before more capital is committed.

Discuss your situation

Experience at a glance

Contributed to nine FDA approvals.

Managed a $200 million global development program.

Led development work from pre-IND through registration.

Selected experience from Jennifer’s executive career.

When to call

  • 01

    The plan is not translating into progress. Progress has stalled and you need someone who can diagnose why and get it moving.

  • 02

    The company is preparing for a bigger step. A financing, a partnership, or a pivotal trial is ahead, and the operation needs to be ready to withstand scrutiny.

  • 03

    You need an operating view before committing capital. Due diligence on a development plan, a team, or a company, from someone who has run these programs.

  • 04

    You are building technology for life sciences customers. You need someone who understands how your buyers actually make development and quality decisions.

You work directly with me

No account layers, no handoffs. We start with the decision in front of you, agree on a scope, and identify what you need to know or change. The engagement may be a focused review, ongoing advise, or fractional operating support.

I’ve rebuilt teams, managed underperforming vendors, and led developmenent work under tight budgets and difficult timeline. Advise has to be useful to the people doing the work.